Robertson Stephens Wealth Management, LLC Relmada Therapeutics, Inc. Transaction History
Robertson Stephens Wealth Management, LLC
- $3.07 Billion
- Q2 2025
A detailed history of Robertson Stephens Wealth Management, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Robertson Stephens Wealth Management, LLC holds 25,000 shares of RLMD stock, worth $57,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 25,000
-0.0%
Holding current value
$57,999
Previous $6,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RLMD
# of Institutions
56Shares Held
5.42MCall Options Held
0Put Options Held
0-
Driehaus Capital Management LLC Chicago, IL740KShares$1.72 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA619KShares$1.44 Million0.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$1.33 Million0.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD397KShares$919,9120.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$844,6580.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $66.4M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...